Vcanbio Cell & Gene Engineering (600645.SS) Earnings Analysis
Vcanbio Cell & Gene Engineering (600645.SS) has no confirmed upcoming earnings date. Trailing P/E 78.84.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 600645.SS next report earnings?
No confirmed upcoming earnings date is currently scheduled for 600645.SS. This page updates as the calendar is published.
600645.SS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-25 | 0.0126 CNY | n/a | n/a | n/a |
| 2025-09-29 | 0.11 CNY | n/a | n/a | n/a |
| 2025-08-27 | 0.06366 CNY | n/a | n/a | n/a |
| 2025-04-24 | -0.07183 CNY | n/a | n/a | n/a |
| 2025-03-31 | 0.06 CNY | n/a | n/a | n/a |
| 2024-08-29 | 0.09 CNY | n/a | n/a | n/a |
600645.SS valuation and analyst view
| Trailing P/E | 78.84 |
|---|---|
| Trailing EPS | 0.22695 CNY |
| Price / book | 2.43 |
| Dividend yield | 0.00% |
| Market cap | 8.41B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Vcanbio Cell & Gene Engineering (600645.SS)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 600645.SS. This page updates as the calendar is published.
Did 600645.SS beat earnings last quarter?
Consensus estimate data was not available for 600645.SS's 2026-04-25 report.
What is 600645.SS's current P/E ratio and EPS?
600645.SS trades at a trailing P/E of 78.84 on trailing EPS of 0.22694589290404588 CNY.
What do analysts rate 600645.SS?
600645.SS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.